Kiniksa Pharmaceuticals International, plc
KNSA
$33.70
$0.130.39%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.79M | -16.95M | -43.19M | -9.07M | -10.23M |
| Total Depreciation and Amortization | 1.50M | 1.57M | 1.70M | 1.84M | 2.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.58M | 41.57M | 42.38M | 18.17M | 32.94M |
| Change in Net Operating Assets | 26.07M | 17.83M | 24.81M | 311.00K | 5.72M |
| Cash from Operations | 66.95M | 44.03M | 25.69M | 11.24M | 30.47M |
| Capital Expenditure | -457.00K | -292.00K | -277.00K | -140.00K | -156.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 25.00K | 25.00K | 25.00K | 25.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.98M | -39.13M | 37.92M | -42.40M | -48.31M |
| Cash from Investing | 3.52M | -39.39M | 37.67M | -42.52M | -48.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28.05M | 16.44M | 17.25M | 15.49M | 7.74M |
| Repurchase of Common Stock | -5.75M | -5.02M | -4.98M | -4.67M | -3.06M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 22.30M | 11.42M | 12.27M | 10.82M | 4.68M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.77M | 16.05M | 75.63M | -20.45M | -13.30M |